![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0383.jpg)
CONCLUSIONS contd..
▪
Our study is the largest trial in a homogenous group of advanced
stage (IIIB) cervical cancer to prove the benefit of relatively simple
and well tolerated concomitant cisplatin chemotherapy regimen over
adequately delivered radiation therapy.
Our study confirms that concomitant weekly ciplatin based chemo-
radiation should be the standard of care in FIGO Stage IIIB Squamous
Cell Cervical Cancer
JAMA Oncol. Feb 2018